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RESEARCH ARTICLE

Integrins promote cytokinesis through the RSK signaling axis

ABSTRACT
Cytokinesis is the final stage in cell division. Although integrins can
regulate cytokinesis, the mechanisms involved are not fully
understood. In this study, we demonstrate that integrin-regulated
ERK (extracellular signal-related kinase) and RSK (p90 ribosomal
S6 kinase) signaling promotes successful cytokinesis. Inhibiting the
activation of ERK and RSK in CHO cells by a mutation in the
integrin b1 cytoplasmic tail or with pharmacological inhibitors results
in the accumulation of cells with midbodies and the formation of
binucleated cells. Activation of ERK and RSK signaling by the
expression of constitutively active RAF1 suppresses the mutant
phenotype in a RSK-dependent manner. Constitutively active RSK2
also restores cytokinesis inhibited by the mutant integrin.
Importantly, the regulatory role of the RSK pathway is not specific
to CHO cells. MCF-10A human mammary epithelial cells and HPNE
human pancreatic ductal epithelial cells exhibit a similar
dependence on RSK for successful cytokinesis. In addition,
depriving mitotic MCF10A cells of integrin-mediated adhesion by
incubating them in suspension suppressed ERK and RSK activation
and resulted in a failure of cytokinesis. Furthermore, inhibition of
RSK or integrins within the 3D context of a developing salivary
gland organ explant also leads to an accumulation of epithelial
cells with midbodies, suggesting a similar defect in cytokinesis.
Interestingly, neither ERK nor RSK regulates cytokinesis in human
fibroblasts, suggesting cell-type specificity. Taken together, our
results identify the integrin–RSK signaling axis as an important
regulator of cytokinesis in epithelial cells. We propose that the
proper interaction of cells with their microenvironment through
integrins contributes to the maintenance of genomic stability by
promoting the successful completion of cytokinesis.
KEY WORDS: Integrins, Cytokinesis, ERK, RSK

INTRODUCTION

Cytokinesis is the final step in cell division that ensures the
proper segregation of genetic and cytoplasmic material between
daughter cells (Green et al., 2012). Cytokinesis is initiated when
the assembly and constriction of the actomyosin contractile ring
drives the ingression of the cleavage furrow, which is regulated
by the localized activation of RhoA and supported by membrane
remodeling mediated by vesicular trafficking (Green et al., 2012;
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Neto and Gould, 2011). The central spindle is assembled during
anaphase and later serves as the framework for the formation of
the midbody. The midbody is an intercellular bridge connecting
the two presumptive daughter cells and consists of microtubules
together with the components and regulators of the abscission
machinery (Green et al., 2012; Neto and Gould, 2011).
Integrins are a-b heterodimeric adhesion receptors that bind
components of the extracellular matrix and together with growth
factor receptors are required for adhesion-dependent cells to
progress through G1 and to enter S phase (Streuli, 2009). Growing
evidence implicates integrins in the regulation of cytokinesis
(Aszodi et al., 2003; Högnäs et al., 2012; Kittler et al., 2007;
Reverte et al., 2006; Thullberg et al., 2007); however, the
molecular mechanisms involved in integrin-regulated cytokinesis
are not well understood. Previous studies from our laboratory
demonstrate that a tyrosine-to-alanine substitution in the
membrane-proximal NPIY motif (Y783A) in the integrin b1
cytoplasmic domain (b1 tail) that suppresses integrin activity also
inhibits cytokinesis (Reverte et al., 2006). Constitutive activation
of the YA (Y783A) mutant rescued cytokinesis (Reverte et al.,
2006), but did not restore stress fibers and focal adhesions (Nieves
et al., 2010). Thus, the ability to form focal adhesions and stress
fibers is not required for successful cytokinesis, at least not in CHO
cells. In the current study, we used this mutant integrin to explore
the role of integrin-regulated MEK–ERK signaling in the
regulation of cytokinesis. Our data indicate that cells adhered by
the mutant integrin are inhibited in ERK activation and
downstream RSK signaling. We show that pharmacological
inhibition of MEK or RSK leads to cytokinesis failure when
CHO cells are adhered by wild-type (WT) integrins and that the
expression of constitutively active Raf or RSK rescues the mutant
phenotype. Integrins also regulate cytokinesis in the human
MCF10A mammary epithelial cell line through a RSK-dependent
pathway. This pathway also plays an important role in cytokinesis
in HPNE, a human pancreatic epithelial cell line as well as in
murine salivary gland epithelial cells during gland morphogenesis
ex vivo. Our results demonstrate a novel role for integrin-regulated
ERK and RSK signaling in promoting cytokinesis and suggest that
integrins do so by regulating key events at the midbody necessary
for abscission. Accumulating evidence links cytokinesis failure to
tumorigenesis (Fujiwara et al., 2005; Galipeau et al., 1996; Ganem
et al., 2007; Högnäs et al., 2012; Jonsdottir et al., 2012; Lv et al.,
2012), suggesting a possible role for integrins as tumor suppressors
owing to their ability to promote successful cytokinesis and thereby
contribute to genomic stability.
RESULTS
Tyrosine to alanine (YA) mutation in the integrin b1 tail results in a
delay in cytokinesis and the accumulation of binucleated cells

To characterize the mechanism by which integrins regulate
cytokinesis, we used CHO cell lines stably expressing chimeric
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integrins containing either the wild-type b1 tail (WT) or the
Y783A mutant b1 tail (YA) in the context of the aIIb-5-b3-1
heterodimeric chimeric integrins (Reverte et al., 2006). We
isolated the function of recombinant integrins by adhering cells to
fibrinogen in CCM1, a serum-free growth-promoting medium, as
previously described (Colello et al., 2012; Nieves et al., 2010;
Reverte et al., 2006). To assay cytokinesis, mitotic cells, isolated
by mitotic shake off, were plated on fibrinogen-coated coverslips
and their progression through cytokinesis was assessed at
30 minute intervals by immunofluorescence microscopy
(Fig. 1A,B). The results indicated that 80% of cells adhered by
the WT integrin successfully completed cytokinesis by 1.5 hours
(Fig. 1B). By contrast, 80% of YA cells were delayed, as
indicated by the persistence of midbodies at 1.5 hours (Fig. 1B).
In addition, by 3 hours, ,20% of YA cells were binucleated with
two centrosomes, indicating failed cytokinesis (Fig. 1B and data
not shown). Statistical analysis indicated that there were
significantly more YA cells with midbodies at 1.5 hours and
significantly more YA cells that failed cytokinesis at 3 hours
compared with WT (supplementary material Table S1).
To demonstrate that effects on cytokinesis were specifically
due to defects in integrin function, we activated the mutant
integrin by replating mitotic cells in the presence of manganese
(Mn2+), an extracellular activator of integrins (Mould et al.,
2002). Activation of the mutant integrin rescued the cytokinesis
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defects (Fig. 1B and supplementary material Table S1).
Additionally, when mitotic cells expressing YA mutant
integrins were adhered to fibronectin by their endogenous a5b1
integrins, YA cells successfully completed cytokinesis (Fig. 1C).
Thus, wild-type integrin function promotes timely progression
through the midbody stage and successful cytokinesis.
Suppression of integrin-regulated MEK–ERK signaling inhibits
cytokinesis

Previous studies have implicated ERK in the regulation of
cytokinesis in some cell types (Kasahara et al., 2007). ERK
activity is inhibited when cells are adhered by the YA mutant
integrin and can be restored by activating the mutant integrin with
Mn2+ (Fig. 2A). Therefore, we asked whether defects in MEK–
ERK signaling contribute to defects in cytokinesis in our system.
For these experiments, logarithmically growing WT cells were
treated with the MEK inhibitor U0126 or DMSO alone for
2 hours to inhibit ERK signaling (Fig. 2B). Mitotic cells were
isolated and adhered to fibrinogen by WT integrins for the
indicated period of time in the presence or absence of the
inhibitor and then analyzed for progression through cytokinesis
(Fig. 2B). The results indicate that inhibition of MEK–ERK
signaling prolongs cytokinesis. At 1.5 hours, more than 50% of
treated cells still had midbodies compared with 20% of untreated
cells, and by 3 hours, 15% of treated cells had failed cytokinesis,

Fig. 1. The YA mutant integrin delays
and inhibits cytokinesis; activating the
mutant integrin rescues these
processes. (A,B) Mitotic cells expressing
WT or YA mutant integrins were collected
and replated on fibrinogen in CCM1 for the
indicated times. (A) Cells were fixed with
glutaraldehyde, stained for a-tubulin to
visualize the microtubules (green) and for
DNA (blue). Images were obtained using
wide-field microscopy. (B) Plotted is the
mean percentage of WT or YA cells in
metaphase or anaphase (white) with
midbodies (blue), successfully completed
cytokinesis (green) or failed cytokinesis
(red) from 0.5 hours to 3 hours with or
without 2 mM manganese (Mn2+).
(C) Mitotic cells expressing WT or YA
mutant integrins were replated on
fibronectin in CCM1 and analyzed at
3 hours for completion of cytokinesis.
Plotted is the mean percentage of cells that
completed or failed cytokinesis. (B,C) One
hundred cells were analyzed from each of
three independent experiments (see
supplementary material Table S1 for
statistical analysis). Scale bar: 10 mm.
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whereas most of the untreated cells had successfully completed
cytokinesis (Fig. 2B). Importantly, these differences are
significant and not inhibitor specific (supplementary material
Table S2). Finally, to confirm that the rescue of the cytokinesis
defect in YA cells treated with Mn2+ was dependent on ERK,
logarithmically growing WT and YA cells were treated with
MEK inhibitor U0126 or DMSO for 2 hours to inhibit ERK
signaling. Mitotic cells were isolated and adhered to fibrinogen
for the times indicated in the presence or absence of Mn2+ and
U0126 and then analyzed for progression through cytokinesis
(Fig. 2C,D). At 3 hours, 20% of WT and 30% of YA cells treated
with Mn2+ and U0126 had failed cytokinesis (Fig. 2C,D). Thus,
the rescue of cytokinesis by Mn2+ is ERK dependent.
RSK functions downstream of ERK to promote cytokinesis

One well-known ERK substrate is the p90 ribosomal S6 kinase
(RSK) protein (Anjum and Blenis, 2008; Romeo et al., 2012;
Yoon and Seger, 2006). Therefore, we determined whether RSK
regulates cytokinesis. RSK activation was compared in cells
adhered by WT and YA integrins. Results showed that RSK
activation was inhibited when cells were adhered by the mutant
integrin, but not when YA cells were adhered to fibrinogen by
their endogenous a5b1 integrins (Fig. 3A). To examine the
role of RSK in cytokinesis, mitotic cells were isolated from
logarithmically growing WT cells that were either pre-treated
with the RSK-specific inhibitors BI-D1870 or SL-0101 (Nguyen,
536

2008; Smith et al., 2005) for 2 hours or treated at shake-off with
BI-D1870 and adhered on fibrinogen. The results indicate that
70–80% of cells treated with inhibitor (pre-treatment or at shakeoff) showed a persistence of midbodies at 1.5 hours, compared
with 50% in control-treated cells (Fig. 3C). Additionally, there
was a significant accumulation (15%) of binucleated cells in all
treatments compared with 2.5% in the control (Fig. 3D). To
identify the time frame of RSK activity required for cytokinesis,
we performed a time course of RSK inhibition (Fig. 3E,F).
Inhibiting RSK during the first 30 minutes after shake-off had no
effect on the outcome of cytokinesis. However, the inhibition of
RSK for the first 60 minutes after shake-off was sufficient to
significantly delay cytokinesis and result in binucleation
(Fig. 3E,F). Additionally, delay and failure of cytokinesis were
observed when the RSK inhibitor was added 30 minutes after
shake-off (Fig. 3E,F). These results indicate that RSK activity is
required at a time after mitotic shake-off, which is consistent with
a role for RSK in promoting abscission.
Raf is an upstream regulator of MEK–ERK signaling.
Therefore, we determined whether experimentally activating
MEK–ERK and RSK by the expression of a conditionally
activated RAF1 mutant was sufficient to rescue cytokinesis when
cells were adhered by YA mutant integrins. For this purpose, we
used an adenovirus that expressed GFP alone as a control or an
adenovirus that expressed GFP together with the DRaf-1:ER
fusion protein, which is activated by the addition of tamoxifen.
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Fig. 2. MEK–ERK signaling regulates cytokinesis in
CHO cells. (A) ERK activation in cells adhered by WT or
mutant integrins with or without 2 mM Mn2+ was analyzed
by western blot using phospho-specific antibodies for
activated ERK. A representative blot is shown on the left.
The right panel shows the average pERK levels normalized
to total ERK 6 s.d. from three independent experiments.
(B) Pharmacological inhibition of MEK results in cytokinesis
failure. Logarithmically growing WT cells were treated with
10 mM U0126 for 2 hours. Mitotic cells were isolated and
replated on fibrinogen with U0126 for the indicated times.
Cells remaining on the plate after shake-off were analyzed
for activated ERK. A representative blot and quantification
of the average pERK levels normalized to total ERK from
three independent experiments are shown on the left. The
right panel shows the percentage of cells in metaphase or
anaphase (white), with midbodies (blue), successfully
completed cytokinesis (green) or failed cytokinesis (red) at
the indicated times. (C,D) Logarithmically growing WT and
YA cells were treated with 10 mM U0126 for 2 hours. Mitotic
cells were isolated and replated on fibrinogen with 2 mM
Mn2+ and U0126 for 3 hours. Percentage of cells with Mn2+
and/or U0126 that failed cytokinesis at 3 hours is shown.
Representative blots and analysis are shown for activated
and total ERK. One hundred individual cells were analyzed
from each of three independent experiments in B–D.
Values are means 6 s.d. *P,0.05, **P,0.005.
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Fig. 3. RSK signaling regulates cytokinesis in CHO cells. (A) RSK activation is inhibited by the YA mutant. Cells were adhered to fibronectin or fibrinogen by
WT or YA mutant integrins for 1 hour in CCM1. RSK activation was determined by western blotting using phospho-specific antibodies to activated RSK. A
representative blot is shown on the left. Mean pRSK levels normalized to total RSK 6 s.d. from three independent experiments is shown on the right.
(B–D) Pharmacological inhibition of RSK results in failed cytokinesis. Mitotic cells were isolated from logarithmically growing WT cells and replated on fibrinogen
and were either pre-treated with 1 mM BI-D1870 (Pre-BI-D1870) or 30 mM SL-0101 (Pre-SL-0101) for 2 hours or treated with 1 mM BI-D1870 (BI-D1870) only at
shake-off. (B) Levels of p-GSK3b (Ser9) with inhibitor were analyzed as a read out for RSK inhibition from the cells remaining on the plate after shake-off.
(C,D) Methanol-fixed cells were stained for a-tubulin and DNA and were assayed for cytokinesis. Plotted is the mean percentage of cells 6 s.d. with midbodies at
1.5 hours or binucleated cells at 3 hours. (E,F) Mitotic cells were isolated from logarithmically growing WT cells and replated on fibrinogen and were treated with
1 mM BI-D1870 for the times indicated. Methanol-fixed cells were stained for a-tubulin, PRC1 and DNA and were assayed for cytokinesis. Plotted is the mean
percentage of cells 6 s.d. with midbodies at 1.5 hours or binucleated cells at 3 hours. One hundred cells were analyzed from each of three independent
experiments shown in C–F. *P,0.05, **P,0.005.

Mitotic cells were isolated from logarithmically growing WT and
YA cells infected with the indicated virus with or without
tamoxifen and replated onto fibrinogen for the indicated times
(Schematic shown in Fig. 4A). Activation of DRaf-1:ER
dramatically upregulated the activation of ERK in cells adhered

by either WT or mutant integrins (Fig. 4B). To determine
whether RSK was required for activated DRaf1:ER to rescue
cytokinesis, mitotic cells infected with the adenoviruses were
isolated with or without tamoxifen and replated on fibrinogencoated coverslips with or without BI-D1870 and assayed for
537
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Fig. 4. Activated Raf-1 rescues ERK and RSK signaling and cytokinesis. (A) Schematic of experimental methodology. (B,C) Activating DRaf-1:ER with
tamoxifen rescues ERK signaling in cells adhered by the mutant integrin. Logarithmically growing cells were infected for 2 hours in serum-free F12 medium with
adenoviruses directing the expression of either GFP or GFP-tagged DRaf-1:ER. Serum-containing F12 medium and 5 mM tamoxifen was added for
16 hours. (B) Mitotic cells were replated on fibrinogen in CCM1 with 5 mM tamoxifen for 1 hour. Shown is a representative western blot used to assay ERK
activation in cells adhered by WT or mutant integrins. (C) Representative blots used to confirm ERK and RSK activation. Note that in A, lysates were analyzed
from cells that were specifically adhered in CCM1 by either WT or the YA mutant integrin. In C, lysates were analyzed from WT and YA cells that were
growing logarithmically in serum-containing medium under conditions where endogenous integrins are engaged and which mask differences caused by the
mutant integrin (Reverte et al., 2006). (D,E) Mitotic cells were isolated and plated on fibrinogen with 1 mM BI-D1870 for the indicated times. Methanol-fixed cells
were stained for a-tubulin and DNA, and assayed for cytokinesis. One hundred individual cells were analyzed from each of three independent experiments.
Plotted is the mean percentage of WT cells and GFP-positive YA cells with midbodies at 1.5 hours (D) and binucleated cells at 3 hours (E) 6 s.d. **P,0.005.
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Activated RSK partially rescues cytokinesis in YA cells

To determine whether the activation of RSK is sufficient to rescue
cytokinesis inhibited by the mutant integrin, YA cells were
transfected with the constitutively active RSK2 mutant, HA-RSK2Y707A (Poteet-Smith et al., 1999). Mitotic cells were isolated from
logarithmically growing cells and plated on fibrinogen to assay
progression through cytokinesis. Cells remaining on the plate were
assayed for RSK activation. HA-RSK2-Y707A-transfected YA
cells dramatically upregulated RSK phosphorylation and signaling
(Fig. 5A). HA-RSK2-Y707A expression rescued the midbody
delay and binucleation phenotype in cells adhered by the mutant
integrin (Fig. 5B,C). At 1.5 hours, significantly fewer cells
adhered by the YA integrin, expressing HA-RSK2-Y707A
(35.1%) were connected by midbodies compared with
untransfected YA cells (54.8%) (Fig. 5B). At 3 hours, only
18.8% of HA-RSK2-Y707A-expressing cells adhered by the YA

Journal of Cell Science

progression through cytokinesis. Cells remaining on the plate
after shake-off were assayed for activation of ERK and RSK
(Fig. 4C). Tamoxifen-activated DRaf1:ER upregulated ERK and
RSK activation (Fig. 4C), rescued the midbody delay and
promoted successful cytokinesis in cells adhered by the YA
integrin (Fig. 4D and E). At 1.5 hours, significantly fewer cells
adhered by the YA integrin, expressing GFP with DRaf1:ER
(22.9%) were connected by midbodies compared with cells
expressing GFP alone (63.4%) or GFP with DRaf1:ER and BID1870 (64.4%) (Fig. 4D). At 3 hours, only 10.4% of cells
adhered by the YA integrin expressing GFP with DRaf1:ER failed
cytokinesis compared with 25.5% of cells expressing GFP alone
and 27.1% cells of expressing GFP with DRaf1:ER and BI-D1870
(Fig. 4E). Thus, our studies support the conclusion that integrinregulated ERK signaling in CHO cells facilitates timely
progression through cytokinesis by a RSK-dependent pathway.
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integrins were binucleated compared with 30.7% untransfected YA
cells (Fig. 5C). It appears that the expression of this RSK construct
only partially rescues the cytokinesis defect in contrast to the
DRaf1:ER construct, which efficiently rescued the cytokinesis
defect in YA cells (Fig. 4). These results indicate that although
RSK is required downstream of activated Raf, it might not be
sufficient to rescue cytokinesis in YA cells, suggesting the
involvement of other Raf–ERK targets.
The integrin–RSK signaling pathway promotes cytokinesis in
epithelial cells, but not in fibroblasts

We determined whether the requirement for RSK signaling in
promoting cytokinesis is specific to CHO cells. Because CHO cells
are epithelial in origin, we examined the role of integrin-regulated
ERK–RSK signaling in cytokinesis in the human mammary
epithelial cell line MCF-10A. For these experiments, mitotic
MCF10A cells were isolated from logarithmically growing
cultures and either replated on a laminin-rich matrix (Homan
et al., 2002; Langhofer et al., 1993) or incubated in suspension and
the progression through cytokinesis was analyzed at 2.5 and
5 hours. Cells adhered to laminin-rich matrices exhibited robust
activation of ERK and RSK; however, ERK and RSK activity were
dramatically downregulated in suspended MCF10A cells at both
2.5 and 5 hours (Fig. 6A). Furthermore, suspended MCF10A
cells showed a delayed midbody phenotype (56.4%) and an
accumulation of binucleated cells (44.4%) compared with cells that
were attached (22.1% and 10.2%, respectively) (Fig. 6B,C)
To determine whether RSK signaling is required for
cytokinesis in MCF10A cells, mitotic cells were isolated and
plated on a laminin-rich matrix with and without BI-D1870. At
2.5 hours, a significant percentage of cells treated with the
inhibitor (43.8%) were delayed in the midbody stage compared
with control DMSO-treated cells (22.8%). At 5 hours, there was
an accumulation of binucleated cells in inhibitor-treated (33.2%)
compared with control (8.0%) cells (Fig. 6D–F). When
cytokinesis is assayed using cells isolated by mitotic shake-off,
the majority of MCF10A cells progress through cytokinesis
without cell–cell contacts. To determine the effect of cell density
on the requirement for RSK signaling, proliferating MCF10A
cells at relatively high density were cultured with and without BID1870, and 25 mitotic MCF10A cells from each control and BID1870-treated samples were imaged by time-lapse microscopy as
they progressed through cytokinesis. The results indicate that
95% of the DMSO-treated MCF10A cells completed cytokinesis

successfully between 2.5 and 4.5 hours. By contrast, 23% of the
BI-D1870-treated cells were delayed at the midbody stage and
41% ultimately failed cytokinesis. To confirm that RSK regulates
cytokinesis, we used an siRNA approach to inhibit RSK
expression. The treatment of MCF10A cells with siRNA
targeting RSK1, RSK2 or a combination of both inhibited the
expression of the respective RSK isoform(s) (Fig. 6G) and
resulted in a significant accumulation of binucleated cells
compared with the cells treated with a non-targeting siRNA
(Fig. 6H). These results suggest that both RSK1 and RSK2 play a
role in the regulation of cytokinesis supporting the idea that
integrin signaling through ERK and RSK contributes to the
timely and successful completion of cytokinesis.
We next asked whether other cells required ERK–RSK
signaling for cytokinesis. We assayed cytokinesis in primary
human foreskin fibroblasts (HFFs) in the presence and absence of
the ERK-specific inhibitor PD184352. Our results indicate that
inhibiting ERK signaling (supplementary material Fig. S1A) in
primary fibroblasts does not affect progression through
cytokinesis. At 1.5 hours, similar percentages of dividing cells
had midbodies: 78.6764.5% (mean 6 s.d.) control cells had
midbodies compared with 7865.3% of cells treated with
PD184352 (supplementary material Fig. S1B). At 3 hours, both
control and treated cells had successfully completed cytokinesis.
This was further corroborated in an immortalized human
fibroblast cell line, BJT (Hahn et al., 1999), where inhibition of
ERK signaling with PD184352 did not affect the progression and
successful completion of cytokinesis (data not shown). We also
used siRNA to inhibit RSK expression in HFF cells to examine
whether RSK played a role in regulating cytokinesis in these
cells. Treatment of cells with non-targeting siRNA or siRNA
targeting RSK1, RSK2 and a combination of both did not
significantly affect the progression through cytokinesis in three
independent experiments. Similar percentages of binucleated
cells were observed in all the siRNA treatments: 1.861.9% (s.d.)
non-targeting compared to 2.960.96% in RSK1, 3.160.2% in
RSK2 and 3.462.7% in RSK1 and RSK2. Thus, activation of
ERK and RSK does not promote cytokinesis in primary and
immortalized human foreskin fibroblasts, suggesting that the
regulatory function of this pathway is a feature of epithelial cells.
We also tested the role of RSK signaling in the human
pancreatic epithelial cell line, HPNE. Since mitotic cells were not
easily isolated from logarithmically growing cultures of HPNE
cells, we used a different experimental approach. We treated
539
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Fig. 5. Activated RSK rescues cytokinesis in YA cells. (A) Representative blots showing relative levels of RSK activation in untransfected WT and YA cells,
and HA-RSK2-Y707A transfected YA cells. (B,C) Mitotic cells were isolated and plated on fibrinogen for the indicated times. Formaldehyde-fixed cells were
stained for a-tubulin, HA and DNA and assayed for cytokinesis. One hundred individual cells were analyzed from each of three independent experiments. Only
HA-positive cells were analyzed in the transfected sample. Plotted is the mean percentage of cells with midbodies at 1.5 hours (B) and binucleated cells at
3 hours (C) 6 s.d. *P,0.05.
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logarithmically growing cultures with BI-D1870, and using timelapse microscopy, imaged 50 mitotic HPNE cells from each
control and BI-D1870-treated samples (supplementary material
Fig. S2A,B). The results indicate that 96% of the control DMSOtreated HPNE cells completed cytokinesis successfully between
1.5 and 2.5 hours. By contrast, 52% of the BI-D1870-treated cells
were delayed at the midbody stage and by 5 hours (end of
filming), 30% had failed cytokinesis. Interestingly, the BID1870-treated cells that did not fail cytokinesis exhibited a
significant delay in the completion of cytokinesis and required
between 2.15 and 3.5 hours to complete cytokinesis.
540

Last, we determined whether RSK played a role in regulating
cytokinesis during tissue morphogenesis as a means to probe the
potential significance of this pathway in vivo. For this purpose,
we chose to examine the branching morphogenesis of the murine
submandibular salivary gland, which requires robust cell
proliferation in addition to cleft initiation and progression and
can be studied using whole organ ex vivo cultures (Daley et al.,
2009). Embryonic day 13 submandibular salivary glands (E13
SMGs) were isolated and cultured for 24 hours and then
incubated in culture medium with BI-D1870 for 8 hours. At
this time, the a6 integrin was expressed on the surface of

Journal of Cell Science

Fig. 6. RSK signaling regulates cytokinesis in MCF10A cells. (A–C) Mitotic cells were isolated from logarithmically growing MCF10A cells and either
adhered (A) on a laminin-rich matrix or incubated in suspension (S) in CCM1 for the times indicated. (A) Shown are representative western blots for the analysis
of ERK and RSK activation. (B,C) The suspended cells were plated on poly-lysine for 5 minutes, methanol-fixed and stained for a-tubulin and DNA and then
assayed for cytokinesis. Plotted is the mean percentage of cells with midbodies at 2.5 hours (B) or binucleated cells at 5 hours (C) 6 s.d. (D–F) Mitotic MCF10A
cells were replated on a laminin-rich matrix in CCM1 with 1 mM BI-D1870 for the times indicated. (D) RSK activation in MCF10A cells with BI-D1870 was
assayed by western blotting. A representative blot is shown. (E,F) Methanol-fixed cells were stained for a-tubulin and DNA and assayed for cytokinesis. Plotted
is the mean percentage of cells with midbodies at 2.5 hours (E) or cells that were binucleated at 5 hours (F) 6 s.d. (G,H) MCF10A cells treated with siRNAs.
Knockdown of RSK1 and RSK2 was determined by western blotting (G). Shown are representative blots. (H) Methanol-fixed cells were stained for a-tubulin,
lamin B1 and DNA and assayed for cytokinesis. One hundred individual cells were analyzed from each of two independent experiments in B–H. Mean
percentage of binucleated cells 6 s.d. is plotted. *P,0.05, **P,0.005, ***P,0.0005.

epithelial cells throughout the developing gland (Fig. 7A) as
previously described (Kadoya and Yamashina, 1993). To identify
cells connected by midbodies we used the established midbody
markers a-tubulin, which localizes to both sides of the midbody
bridge and PRC1, which localizes to the central midbody ring
(Green et al., 2012). When we compared glands with and without
the inhibitor, we found that there was a significant increase in the
number of epithelial cells connected by midbodies in the
inhibitor-treated glands (Fig. 7C,D), whereas there was no
significant difference in the number of metaphase or anaphase
cells in control and treated glands (Fig. 7C,E). Furthermore, when
dissociated glands were replated onto laminin matrices, we found
that 11.2560.7% of cells expressing integrin a6 from BI-D1870treated glands were binucleated compared with 0.4960.7% of
cells expressing a6 from DMSO-treated glands. This set of
experiments corroborates the idea that epithelial cells require
RSK signaling for timely progression through cytokinesis.
Notably, we did not detect mesenchymal cells in mitosis or
with midbodies with or without the inhibitor. Thus, conclusions
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of the effects of RSK inhibition in fibroblasts during salivary
gland morphogenesis cannot be made from these experiments.
We also tested whether integrin function was required for
cytokinesis during salivary gland morphogenesis. Because the
integrin a6 subunit was expressed on the surface of epithelial cells
of the developing gland, but not by mesenchymal cells (Fig. 7A),
we inhibited the a6 integrin with function-blocking antibodies.
Submandibular salivary glands from day 12 mouse embryos were
grown as explants in culture for 24 hours with 25 mg/ml control or
a6 function-blocking antibodies. We found a significant increase in
the number of epithelial cells connected by midbodies in the
antibody-treated glands compared with control glands (Fig. 7F).
There was no significant difference in the number of metaphase or
anaphase cells in control and treated glands (Fig. 7G), although
cleft formation was delayed (not shown) as previously reported in
a6-integrin-inhibited salivary gland organ explants (Kadoya et al.,
1995; Sakai et al., 2003). This experiment corroborates the idea
that epithelial cells in the developing salivary gland require
integrin function for timely progression through cytokinesis.

Fig. 7. Cells with midbodies accumulate in explant cultures of mouse embryonic salivary glands inhibited for RSK signaling. (A–E) Submandibular
salivary glands from day 13 mouse embryos were grown as explants in culture for 24 hours and treated with 3 mM BI-D1870 for 8 hours before being fixed and
stained for analysis by confocal microscopy. (A) A confocal z-slice through a salivary gland showing a6 integrin staining in all the cells in the epithelial
compartment (proacinar buds and ducts) of the gland. The asterisks and filled triangles identify the proacinar and duct portions of the gland respectively. An
enlarged image of a confocal z-slice through a proacinar end bud is shown on the right. (B) A confocal z-slice through an end bud of the salivary gland stained for
a-tubulin (red), PRC1 (green) and DNA (blue). Arrowheads indicate mitotic cells. Arrows indicate midbodies that are shown magnified in the insets. (C) A
representative western blot of whole gland lysates with BI-D1870 probed for p-GSK3b as a readout of RSK activity. (D) Plotted are the number of cells in
telophase or with midbodies per 1000 cells in DMSO and BI-D1870-treated glands from two independent experiments (n530 buds). (E) Number of mitotic cells
(metaphase and anaphase) per 1000 cells in glands with BI-D1870 from two independent experiments (n530 buds). (F,G) Submandibular salivary glands from
day 12 mouse embryos were grown as explants in culture for 24 hours with 25 mg/ml control rat IgG or anti-integrin a6 (GoH3) before being fixed and stained for
analysis by confocal microscopy. (F) Number of cells in telophase or with midbodies per 1000 cells from two independent experiments (n540 buds). (G) Number
of mitotic cells per 1000 cells from two independent experiments (n540 buds). *P,0.05. Scale bars: 10 mm.
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DISCUSSION

The importance of cell adhesion for successful cytokinesis has
been recognized for over a decade (Ben-Ze’ev and Raz, 1981;
Orly and Sato, 1979; Winklbauer, 1986). A direct role for
integrins in the regulation of cytokinesis was later demonstrated
in both in vivo and in vitro. The first was the demonstration that
conditional deletion of integrin b1 in chondrocytes in developing
mice leads to cytokinesis failure and chondrodysplasia (Aszodi
et al., 2003). Later, cell culture studies showed that suppression of
integrin function either by a mutation in the integrin b1 tail or by
the inhibition of integrin expression with siRNA caused
cytokinesis failure (Kittler et al., 2007; Reverte et al., 2006).
Furthermore, defective b1 integrin recycling was also shown to
inhibit cytokinesis further supporting the importance of integrins
in promoting successful cytokinesis (Pellinen et al., 2008). Our
current study identifies a novel and cell-type-specific role for
integrin-regulated RSK signaling in the regulation of cytokinesis.
Multiple substrates have been identified for RSK, including
both cytoplasmic and nuclear proteins (Anjum and Blenis, 2008;
Romeo et al., 2012). GSK3b is one of the known RSK substrates.
GSK-3b phosphorylates several microtubule-binding proteins to
regulate microtubule dynamics (Etienne-Manneville, 2013). RSK
phosphorylates and inhibits GSK-3b activity. Thus, RSK by
targeting GSK-3b, could regulate cytokinesis by impacting
microtubule function.
Filamin A is the only RSK substrate that has been reported to
localize to the midbody (Mondal et al., 2012; Nunnally et al.,
1980; Playford et al., 2006). Recent studies indicate that filamin
A recruits BRCA2 to the midbody, where it promotes the
midbody localization of components of the ESCRT complex
(Mondal et al., 2012). Thus, it is tempting to speculate that
integrin-regulated, RSK-dependent phosphorylation of filamin A
promotes cytokinesis by localizing BRCA2 to the midbody.
However, we do not know whether the phosphorylation of filamin
A regulates its function at the midbody; furthermore, the role of
BRCA2 in cytokinesis is not universally accepted (Lekomtsev
et al., 2010).
Interestingly, RSK has been shown to suppress integrin activity
by phosphorylating filamin A (Gawecka et al., 2012; Vial and
McKeown-Longo, 2012). It has been proposed that RSK2
functions in a feedback loop to modulate integrin activity
during cell migration with integrins activating RSK, which
feeds back to negatively regulate integrin activity (Gawecka
et al., 2012). One could hypothesize that a similar RSK2dependent modulation of integrin activity could occur during
cytokinesis. A recent study using HeLa cells demonstrated that
tension at the midbody prolonged cytokinesis, whereas the release
of tension induced abscission (Lafaurie-Janvore et al., 2013).
Tension at the midbody could be promoted by integrin and
release of tension by the downregulation of integrin activity. In
this regard, it is interesting to note that in our CHO cell model,
locking integrins in an activated conformation either by treating
cells with Mn2+ or with activating antibodies promoted
cytokinesis and prevented the accumulation of cells delayed in
cytokinesis (Reverte et al., 2006) (Fig. 1).
The completion of cytokinesis is regulated by the recruitment
of the abscission machinery to the midbody, including
components of the exocyst and ESCRT complexes (Neto and
Gould, 2011). The exocyst complex targets vesicular trafficking
to the midbody in preparation for abscission. Components of the
ESCRT complex mediate abscission upon the depolymerization
and/or severing of microtubules remaining in the midbody. We
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propose that RSK signaling (directly or indirectly) regulates the
localization or activity of components of these complexes and
thereby promotes efficient and successful cytokinesis. Our
analysis of the time frame when RSK signaling is required to
promote cytokinesis is consistent with this idea. Based on the
known RSK substrates, it is possible that RSK phosphorylates
multiple substrates to promote abscission. RSK activity might
target midbody components, microtubules and/or integrin
activity. Our RSK siRNA results in MCF10A cells suggest that
both RSK1 and RSK2 isoforms regulate cytokinesis. It will be
interesting to explore whether these isoforms play distinct roles in
the regulation of cytokinesis.
ERK is a known activator of RSK. We recently identified a
novel role for integrins in promoting microtubule nucleation from
the interphase centrosome through an ERK-dependent pathway
(Colello et al., 2012). However, we do not know whether this
regulation involves RSK signaling. Interestingly, although ERK
promotes microtubule nucleation from the interphase centrosome
in both CHO cells and HFFs (Colello et al., 2012), the
suppression of ERK signaling inhibits cytokinesis in CHO cells,
but not HFFs. These results suggest that the effects of ERK
inhibition on microtubule nucleation and cytokinesis are
separable. It is also possible that the level of microtubule
nucleation that occurs in ERK inhibited HFFs is sufficient to
support microtubule function during cytokinesis.
Other laboratories have implicated ERK in the regulation of
abscission (Kasahara et al., 2007). They proposed that in HeLa S3
cells, ERK becomes activated by Src signaling in early mitosis
and is then trafficked to the midbody by a Rab11-dependent
mechanism, where it signals abscission. Our studies have
identified RSK as an important downstream target of ERK in
the regulation of cytokinesis in CHO cells. Thus, it is possible
that RSK is activated by ERK at the midbody. Future studies will
examine whether active RSK localizes to the midbody.
Others have shown that activation of Raf-1 can activate
signaling pathways independent of MEK–ERK (Pearson et al.,
2000). RSK-dependent regulation of integrin activity occurs by
ERK-dependent and independent mechanisms (Gawecka et al.,
2012; Vial and McKeown-Longo, 2012). We found that the
inhibition of either ERK or RSK led to a similar phenotype in
CHO cells, which suggests that ERK and RSK are functioning
together in the same pathway in these cells. Consistent with this
notion, DRaf1:ER leads to the activation of both ERK and RSK
(Fig. 4). Nonetheless it is important to note that we have not ruled
out the possibility that RSK regulates cytokinesis in MCF10A,
HPNE and salivary gland epithelial cells by an ERK-independent
mechanism, because we have not tested the requirement for ERK
in the cell types.
Our results, together with findings from others (Kasahara et al.,
2007), indicate that some pathways regulate cytokinesis in a celltype-dependent manner. We found that RSK promotes cytokinesis
in various types of epithelial cells without affecting integrin surface
expression (supplementary material Fig. S3), including murine
salivary gland epithelial cells during ex vivo morphogenesis, but
not in human fibroblasts. Unfortunately, we cannot make
conclusions regarding embryonic fibroblasts associated with
salivary gland morphogenesis because we did not detect
mesenchymal cells in mitosis or cytokinesis with or without
RSK inhibitor in our analysis. Kasahara and colleagues indicated
that HeLa (ovarian cancer), A431 (squamous cell cancer) and Cos1 (monkey kidney fibroblastic-like) cells required MEK–ERK
signaling for cytokinesis, whereas SYF fibroblasts, MCF-7 (breast
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cancer) and HCT116 (colon cancer) do not. In light of our findings,
it would be interesting to compare the sensitivity of these cell lines
to RSK inhibition.
In summary, our data indicate that both adhesion-dependent and
-independent mechanisms support the completion of cytokinesis.
We have shown that RSK signaling promotes cytokinesis
downstream of integrins in epithelial cells in culture, that RSK
and a6 integrins regulate cytokinesis during tissue morphogenesis
ex vivo and that RSK regulates cytokinesis in a cell-type-specific
manner. Others have shown that cytokinesis failure can lead to
aneuploidy and tumorigenesis and that tetraploid cells are present
at early stages of tumors from different origins (Fujiwara et al.,
2005; Galipeau et al., 1996; Ganem et al., 2007; Högnäs et al.,
2012; Jonsdottir et al., 2012; Lv et al., 2012), suggesting that the
proper interaction of cells with components of the ECM might
contribute to maintaining genomic stability by promoting
successful cytokinesis. More studies are needed to understand the
significance of cell-type requirements for specific signaling
pathways, the availability of redundant pathways, as well as
integrin-dependent regulation of cytokinesis both in the context of
developmental processes and tumorigenesis.
MATERIALS AND METHODS
Cell culture

Chinese hamster ovary (CHO K1) cell lines stably expressing aIIb-5b3-1
recombinant chimeric integrins containing the WT or the Y783A (YA)
b1 tail (Reverte et al., 2006) and HFFs were maintained as previously
described (Colello et al., 2010). The immortalized human mammary
epithelial cell line MCF10A was maintained as previously published
(Debnath et al., 2003). The immortalized human pancreatic nestinexpressing cell line (hTERT-HPNE, ATCC) was maintained according to
ATCC guidelines. For cytokinesis experiments, cells were replated in the
serum-free growth-promoting medium CCM1 (Hyclone) as indicated.
Antibodies and other reagents

The following antibodies were purchased from Santa Cruz Biotechnology
Inc.: mouse anti-a-tubulin (DM1a); rabbit anti-PRC1; rabbit anti-Raf-1;
rabbit anti-RSK1; and goat anti-RSK2. The following antibodies were
purchased from Cell Signaling: mouse anti-p-ERK1/2; rabbit anti-p-RSK
(Ser380); rabbit anti-p-GSK3b; and mouse anti-pan-GSK3b. Mouse antipan-ERK was from BD Transduction Laboratories; rabbit anti-panRSK
was from R and D Systems; mouse anti-HA antibody was from Covance;
rat IgG, whole molecule was from Pierce, and rat anti-integrin-alpha-6
(GoH3) was from BD Biosciences. Alexa-Fluor-conjugated secondary
antibodies were obtained from Invitrogen. The Cy2- and Cy3-conjugated
F(ab9)2 fragments from Jackson ImmunoResearch were used as
secondary antibodies for salivary gland experiments. DNA was stained
using Hoechst 33342 from Invitrogen or Draq5 from Cell Signaling. The
MEK-specific inhibitors U0126 and PD98059 were from Cell Signaling
and PD 184,354 (CI-1040) was from Santa Cruz Biotechnology. RSKspecific inhibitor BI-D1870 was from Enzo Lifesciences and SL-0101
was from Toronto Research Chemicals. Tamoxifen was purchased from
Krackeler Scientific. The constitutively active RSK2 plasmid pKH3RSK2 Y707A was previously described (Poteet-Smith et al., 1999).
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HPNE cells were difficult to isolate, effects of RSK inhibition on
cytokinesis were determined by time-lapse imaging. Cells in metaphase
were identified in logarithmically growing cultures by phase-contrast
microscopy (see supplementary material Fig. S2) and then followed by
time-lapse microscopy from metaphase to the completion of cytokinesis.
Complete separation of daughter cells was scored as successful and
formation of binucleated cells was scored as failed cytokinesis. The delay
at the midbody stage was measured from the time of appearance of the
midbody ring until the cells completed or failed cytokinesis.
Western blotting

Western blotting was used to assay the activation of ERK and RSK and to
monitor the expression of recombinant proteins and RSK isoforms
following siRNA knockdown. Cells were lysed in mRIPA buffer
containing phosphatase (Fisher Scientific) and protease inhibitor
cocktails (Krackeler Scientific) and equal amounts of protein (25–
30 mg) were separated by SDS-PAGE and transferred to nitrocellulose
for antibody analysis.
Microscopy

Microscopy was performed using a Nikon inverted TE2000-E
microscope equipped with phase contrast and epifluorescence, a digital
CoolSNAP HQ camera, a Prior ProScanII motorized stage, a C1 confocal
system (Nikon) and a NIS-Elements acquisition and analysis software.
Live imaging was performed in an environmental chamber maintained at
37 ˚C with 5% CO2. Images were taken every 5 minutes for 3 hours or
5 hours as indicated and processed using NIS-Elements software.
Generation of DRaf-1:ER-expressing adenovirus

An acceptor cassette with Xho1 and BamH1 restriction sites on the 59 and 39
ends, respectively, was amplified by PCR and cloned into pAdtrack-GFP,
which was then genetically recombined with pAdEasy, as previously
described (He et al., 1998; Meadows et al., 2001) to generate the ‘acceptor’
vector for Cre-mediated recombination, pAdeasy-ACC. A BamH1 fragment
containing DRaf-1:ER was isolated from pBabe-puro-DRaf-1:ER (a
generous gift from Martin McMahon, UCSF Medical School) and cloned
in to the BamH1 site of pDNR3 (Clontech Laboratories Inc.) to generate a
DRaf-1:ER*-pDNR3 transfer vector, which was then recombined into the
pAdeasy-ACC vector using Cre recombinase following the protocols
outlined for the Creator System (Clontech Laboratories Inc.).
Transfection

MCF10A cells were transfected with siRNAs as previously published (Colello
et al., 2010). Non-targeting, RSK1 and RSK2 siRNA pools were from
Dharmacon/Thermo Scientific. One or two rounds of transfection were
performed to get optimal knockdown of the RSK proteins in HFF and
MCF10A cells respectively. After 3 days, the cells were trypsinized and
replated on a laminin-rich matrix and fixed and analyzed for binucleation.
CHO cells were transfected with the constitutively active RSK plasmid using
the Amaxa cell line nucleofector kit T from Lonza using their optimized
protocol for CHO-K1 cells. The following changes were made: 500 ml of
warm complete F12 medium was added to the cuvette and the cells were
gently transferred to a plate of pre-warmed complete F12 medium (avoiding
repeated aspiration of the sample) and incubated at 37˚C for 48 hours. Mitotic
cells were isolated and replated to assay cytokinesis.
Salivary gland explant culture

Cytokinesis assay

Loosely attached mitotic cells were gently shaken off from
logarithmically growing cultures and replated in CCM1 onto
fibrinogen- or fibronectin-coated coverslips and incubated at 37 ˚C as
indicated. Cells were fixed and stained and then analyzed for progression
through cytokinesis by immunofluorescence microscopy. To compare
cytokinesis success in adhered and suspended cells, mitotic MCF10A
cells were isolated and either plated on a laminin-5-rich matrix (Homan
et al., 2002) for 2.5 and 5 hours or left in suspension with intermittent
shaking for 2.5 and 5 hours. The suspended cells were then plated on
poly-lysine for 5 minutes and then analyzed as above. Because mitotic

Mouse submandibular salivary glands (SMGs) were dissected from
timed-pregnant female mice (strain CD-1, Charles River Laboratories) at
embryonic day 12 (E12) or 13 (E13) with the day of plug discovery
designated as E0, in accordance with protocols approved by the
University at Albany IACUC. The SMGs were cultured as described
previously (Daley et al., 2009; Sequeira et al., 2012). For experiments
using integrin function-blocking antibodies, isolated E12SMGs were
preincubated with either 25 mg/ml control antibody or GoH3 anti-integrin
a6 antibody for 45 minutes at room temperature before plating. The
glands were then incubated in the presence of control or GoH3 antibodies
at 37˚C for 24 hours. The glands were then fixed in ice-cold methanol for
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20 minutes and permeabilized with 0.4% Triton X-100 for 30 minutes with
gentle shaking. Following a wash step with PBS-Tween-20, the glands were
blocked and stained for immunofluorescence microscopy as described
previously (Larsen et al., 2003). For the RSK inhibitor experiments, isolated
E13 MSGs were cultured for 24 hours; the medium was replaced on the
E13SMGs with medium with or without 3 mM BI-D1870 and the glands
were cultured for an additional 8 hours. The glands were then fixed and
processed for immunofluorescence microscopy as described above.
To determine whether RSK inhibition resulted in the formation of
binucleated cells, 20 glands were isolated from 10 E13 mice in each of
two independent experiments. Glands were cultured and incubated with
or without inhibitor as described above. We found it is difficult to
quantify failed cytokinesis with any confidence by determining the
presence of binucleated cells in the context of the 3D gland. Therefore,
after inhibitor treatment, glands were dissociated into individual cells as
previously described (Sequeira et al., 2013; Wei et al., 2007). These cells
were plated in DMEM/F12 containing 10% FBS onto laminin-rich
matrix, gently centrifuged to promote their association with the matrix
and incubated for 2 hours at 37 ˚C to allow them to adhere and spread.
The cells were fixed and stained for DNA, the a6 integrin to identify
epithelial cells and lamin B1 to visualize the nuclear membrane.
Binucleated cells were then identified microscopically.
Analysis of cytokinesis in salivary glands

Confocal z-stacks were obtained using Nikon EZ-C1 software with a step
size of 0.5 mm. Planes were chosen for analysis based on clear resolution
of a-tubulin staining of cells in the epithelial compartment of the glands.
Midbodies and mitotic figures were identified based on distinct a-tubulin
and PRC1 staining (as shown in Fig. 7A,B). Analyses were normalized to
cell number as determined by the number of nuclei using the Bitplane
scientific software Imaris. Briefly, the chosen planes were cropped to
exclude most of the mesenchymal compartment and viewed in SURPASS
mode for further analysis. Using the Surfaces option, a contoured image
of the epithelial compartment (bud) was masked and separated for
analysis from the rest of the image. An automated nuclei count was
generated using the Spots option keeping the spot size constant at 4.5 mm
for all images. This was checked visually using the ortho-slicer view to
ensure that all nuclei were included in the spot count. Numbers of cells in
telophase or with midbodies or mitotic (meta/anaphase) cells per 1000
cells were used to plot the graphs shown in the figure.
Statistical analysis

Graphpad Prism software was used to perform statistical analysis on the
data generated from the experiments. Where multiple comparisons were
made (.two sets of data), a one-way ANOVA with either a Dunnett’s
test or Bonferroni’s test for post-hoc analysis was performed. Where two
sets of data were being compared, a Student’s t-test was used. P,0.05
was considered statistically significant.
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